| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/05/2011 | US20110104685 Method for testing microorganism or the like and testing apparatus therefor |
| 05/05/2011 | US20110104684 Methods and Compositions for Identifying Sulfur and Iron Modifying Bacteria |
| 05/05/2011 | US20110104683 Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome |
| 05/05/2011 | US20110104682 Rna detection assays |
| 05/05/2011 | US20110104681 Novel transgene assay using stable agrobacterium rhizogenes transformation |
| 05/05/2011 | US20110104680 Recurrent gene fusions in lung cancer |
| 05/05/2011 | US20110104679 Methods and Compositions for the Diagnosis and Treatment of Angiogenic Disorders |
| 05/05/2011 | US20110104678 Polymerase inhibitor and method of using same |
| 05/05/2011 | US20110104677 Selective restriction fragment amplification: fingerprinting |
| 05/05/2011 | US20110104676 Hybridization chain reaction amplification for in situ imaging |
| 05/05/2011 | US20110104675 Methods and Compositions for Diagnosing Carcinomas |
| 05/05/2011 | US20110104674 Snp detection and other methods for characterizing and treating bipolar disorder and other ailments |
| 05/05/2011 | US20110104673 NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY |
| 05/05/2011 | US20110104672 Method For Detection And/Or Analysis Of Yeast And Mold In Filterable Liquids |
| 05/05/2011 | US20110104671 Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
| 05/05/2011 | US20110104670 Method, device and molecular biology kit for extracting amplified genetic material |
| 05/05/2011 | US20110104669 Method to predict iris color |
| 05/05/2011 | US20110104668 Nucleic acid ligands against infectious prions |
| 05/05/2011 | US20110104667 Methods for identifying nucleic acid ligands |
| 05/05/2011 | US20110104666 Insulin resistance marker |
| 05/05/2011 | US20110104665 Mutant sodium channel nav 1.7 and methods related thereto |
| 05/05/2011 | US20110104664 Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents |
| 05/05/2011 | US20110104663 Method for the Quantification of Methylated DNA |
| 05/05/2011 | US20110104662 Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV |
| 05/05/2011 | US20110104661 Degradable polyacrylamide gel |
| 05/05/2011 | US20110104660 Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions |
| 05/05/2011 | US20110104659 Device for biochemical processing and analysis of a sample |
| 05/05/2011 | US20110104658 Synthetic Microfluidic Blood-Brain Barrier |
| 05/05/2011 | US20110104657 Method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker |
| 05/05/2011 | US20110104306 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 05/05/2011 | US20110104300 Methods for Screening Chemical, Biological, and Physical Agents for Disinfecting Infectious Norovirus |
| 05/05/2011 | US20110104257 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104202 Modified Influenza Virus For Monitoring And Improving Vaccine Efficiency |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104183 Use of sip1 as determinant of breast cancer stemness |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104177 Histone deacetylase inhibitors, combination therapies and methods of use |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104153 Use of immunoregulatory nk cell populations for predicting the efficacy of anti-il-2r antibodies in multiple sclerosis patients |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104140 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 05/05/2011 | US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof |
| 05/05/2011 | US20110104126 Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same |
| 05/05/2011 | US20110104124 Mesodermal-like cell population for treating ischemia in mammals |
| 05/05/2011 | US20110104122 Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104117 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 05/05/2011 | US20110104075 129Xe BIOSENSORS AND THEIR USE |
| 05/05/2011 | US20110104071 Methods and systems for spatially identifying abnormal cells |
| 05/05/2011 | US20110104070 Site specific fluorescence and contrast marker for same |
| 05/05/2011 | US20110104066 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 05/05/2011 | US20110104065 Genetic alteration associated with pre-malignant cancer |
| 05/05/2011 | US20110104062 Biomarkers for Head-And-Neck Cancers and Precancers |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100903 Method for determining physiological state of microbial community and wastewater treatment method |
| 05/05/2011 | US20110100822 Device and method for quantitatively determining an analyte, a method for determining an effective size of a molecule, a method for attaching molecules to a substrate, and a device for detecting molecules |
| 05/05/2011 | DE102009051438A1 Fluoreszenzfarbstoffe Fluorescent dyes |
| 05/05/2011 | DE102009050308A1 New polyribonucleotide, having protein encoding sequence that comprises combination of unmodified and modified nucleotides and is obtained from mixture of ATP, guanosine-, cytidine- and uridine-triphosphate, useful e.g. for coating implant |
| 05/05/2011 | DE102006022569B4 Spezies-unabhängiges Nachweisverfahren für biologisches Material Species-independent detection method for biological material |
| 05/05/2011 | CA2779495A1 Encoding text into nucleic acid sequences |
| 05/05/2011 | CA2779270A1 Method of predicting risk of preterm birth |
| 05/05/2011 | CA2779144A1 Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same |
| 05/05/2011 | CA2779086A1 Determination of 17q gain in neuroblastoma patients by analysis of circulating dna |
| 05/05/2011 | CA2779039A1 Generating induced pluripotent stem cells and progenitor cells from fibroblasts |
| 05/05/2011 | CA2778985A1 Gna11 mutations in melanoma |
| 05/05/2011 | CA2778926A1 Means and methods for non-invasive diagnosis of chromosomal aneuploidy |
| 05/05/2011 | CA2778539A1 Methods for diagnosing irritable bowel syndrome |
| 05/05/2011 | CA2778329A1 Device and apparatus |
| 05/05/2011 | CA2778294A1 Circulating mirnas as non-invasive markers for diagnosis and staging in prostate cancer |
| 05/05/2011 | CA2778245A1 Methods and systems for reducing dna fragmentation in a population of sperm cells |
| 05/05/2011 | CA2778144A1 Use of methylsulfonylmethane (msm) to modulate microbial activity |
| 05/05/2011 | CA2777906A1 Method for the prognosis of ovarian carcinoma |
| 05/05/2011 | CA2773471A1 Tomato fruit having increased firmness |
| 05/04/2011 | EP2317314A1 Sensors |
| 05/04/2011 | EP2316977A1 Reagents, methods and libraries for bead-based amflication |
| 05/04/2011 | EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 05/04/2011 | EP2316975A1 Asynchronous primed PCR |
| 05/04/2011 | EP2316974A1 Dark quenchers for donor-acceptor energy transfer |
| 05/04/2011 | EP2316973A1 Detection methods for disorders of the lung |
| 05/04/2011 | EP2316972A1 Circulating miRNAs as non-invasive markers for diagnosis and staging in prostate cancer |
| 05/04/2011 | EP2316971A1 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 05/04/2011 | EP2316970A2 Methods for the treatment and diagnosis of cancer |
| 05/04/2011 | EP2316969A1 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 05/04/2011 | EP2316968A1 Antisense modulation of apolipoprotein (A) expression |
| 05/04/2011 | EP2316967A1 Methods and sequences to preferentially suppress expression of mutated huntingtin gene. |
| 05/04/2011 | EP2316966A1 CIZ1 replication protein |
| 05/04/2011 | EP2316965A1 Introduction of sequence elements in nucleic acids |
| 05/04/2011 | EP2316964A1 Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample |
| 05/04/2011 | EP2316949A1 Limnanthes oil genes |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316936A1 Method for analysis/identification of antibody gene at one-cell level |
| 05/04/2011 | EP2316935A1 Aptamer against il-17 and use thereof |
| 05/04/2011 | EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 05/04/2011 | EP2316848A1 Transporter genes OATP-B, C, D and E |